Clinical Study of Single Dose IL-6R mAb Injection in RA Patients

NCT05232396 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: IL-6R Monoclonal Antibody Injection 4mg/kg
BIOLOGICAL: IL-6R Monoclonal Antibody Injection 6mg/kg
BIOLOGICAL: IL-6R Monoclonal Antibody Injection 8mg/kg
BIOLOGICAL: Tocilizumab Injection 8mg/kg

Sponsor

Beijing VDJBio Co., LTD.